SARS-CoV-2 Human Challenge Studies. Reply

N Engl J Med. 2021 Oct 28;385(18):1728. doi: 10.1056/NEJMc2113574. Epub 2021 Sep 29.

Authors

Garth Rapeport¹, Christopher Chiu¹, Helen McShane²

Affiliations

¹ Imperial College London, London, United Kingdom.
² University of Oxford, Oxford, United Kingdom.

PMID: 34587381
DOI: 10.1056/NEJMc2113574

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Viral
COVID-19*
Humans
Lung
SARS-CoV-2*

Substances

Antibodies, Viral